Anti-Amyloid Therapy
Anti-amyloid therapies target the underlying biology of Alzheimer’s disease by reducing amyloid plaques in the brain. This collection includes guidance and tools to support readiness, communication, monitoring and shared decision-making around these treatments.
Explore Treatment Considerations, Clinical Resources and Patient Communication Strategies.
Support for evaluating, implementing and discussing anti-amyloid therapies in clinical practice.
Treatment
Lecanemab Resources for Health Care Professionals
A downloadable toolkit to help providers evaluate treatment readiness, plan care and coordinate support for individuals starting Lecanemab. It includes checklists, planning templates and practical resources for clinic workflows.
Treatment
Discussing Anti-Amyloid Treatments with Patients
A resource to support clear, person-centered conversations about anti-amyloid therapies. Includes suggested language, risk framing and tips for supporting shared decision-making.
Treatment
Amyloid-Related Imaging Abnormalities (ARIA) in Anti-Amyloid Therapies for Alzheimer's Disease
Clinical guidance on identifying, monitoring and managing ARIA — a known side effect of anti-amyloid treatment. This resource outlines imaging protocols, response strategies and communication tips for providers.
Treatment
Donanemab Resources for Health Care Professionals
Guidance and planning resources to help providers evaluate, prepare for and manage treatment with Donanemab in clinical practice.
See Related Content
You may also like these related items.
